Effectiveness Study on Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3

• Status: Unknown status
• Trial end date: 2008-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether fosinopril and losartan are effective in the treatment of patients with Chronic Kidney Disease(CKD) stage 3.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Shanghai Municipal Health Bureau
• Treatments: Fosinopril; Losartan

Criteria

Inclusion Criteria:

• Patients aged 18-75 years old

• Roll out secondary renal diseases

• Do not use steroids and immunosuppresive drugs

• ACEI/ARB treated patients should have 7-14 days wash out period，SiDBP< 110mmHg

• Willing and able to comprehend and give written informed consent

• Willing to follow-up regularly

Exclusion Criteria:

• Use steroids and immunosuppresive drugs

• Secondary renal diseases

• Acute cardio-cerebral diseases within 6 months

• Post renal transplantation

• Pregnant/Nursing women

• History of hypersensitivity to ACEI/ARB

• Refuse to join clinical trial